<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: BACKGROUND: Fascin-1 is an actin-bundling protein expressed in many human <z:mp ids='MP_0002038'>carcinomas</z:mp>, although absent from most <z:mpath ids='MPATH_458'>normal</z:mpath> epithelia </plain></SENT>
<SENT sid="1" pm="."><plain>Fascin-1 promotes filopodia formation, migration and invasion in <z:mp ids='MP_0002038'>carcinoma</z:mp> cells; in mouse xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> models it contributes to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Fascin-1 is an interesting candidate biomarker for aggressive, metastatic <z:mp ids='MP_0002038'>carcinomas</z:mp> but data from individual studies of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> have not yet been pooled systematically </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: This systematic review was conducted in accordance with PRISMA guidelines, using fixed and random effects models, as appropriate, to undertake meta-analysis </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 26 immunohistochemical studies of 5 prevalent human <z:mp ids='MP_0002038'>carcinomas</z:mp> were identified for meta-analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Fascin-1 was associated with increased risk of mortality for breast (pooled hazard ratio, (HR) = 2.58; 95% confidence interval (CI) 1.48 to 4.52; P = 0.001), colorectal (HR = 1.60 (1.37 to 1.86; P &lt;0.001) and <z:hpo ids='HP_0011459'>esophageal carcinomas</z:hpo> (HR = 1.35; CI 1.13 to 1.60; P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no evidence of association of fascin-1 with mortality in gastric and <z:mp ids='MP_0008714'>lung carcinomas</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Fascin-1 was associated with increased risk of disease progression in breast (HR = 2.48; CI 1.38 to 4.46; P = 0.002) and colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (HR = 2.12; CI 1.00 to 4.47; P = 0.05), but not with progression of <z:mp ids='MP_0008714'>lung carcinomas</z:mp> (HR = 0.95; CI 0.49 to 1.85; P = 0.9) </plain></SENT>
<SENT sid="8" pm="."><plain>Fascin-1 was associated with increased risk of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in colorectal (pooled risk ratio (RR) = 1.47; CI 1.26 to 1.71; P &lt;0.001) and gastric <z:mp ids='MP_0002038'>carcinomas</z:mp> (RR = 1.43; CI 1.21 to 1.70; P &lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>There was no evidence of association of fascin-1 with lymph node <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">metastasis in lung</z:e> or <z:hpo ids='HP_0011459'>esophageal carcinomas</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Fascin-1 was associated with increased risk of distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in colorectal (RR = 1.70; CI 1.18 to 2.45; P = 0.004) and gastric <z:mp ids='MP_0002038'>carcinomas</z:mp> (RR = 1.93; CI 1.21 to 3.33; P = 0.02) </plain></SENT>
<SENT sid="11" pm="."><plain>No association with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:hpo ids='HP_0011459'>esophageal carcinomas</z:hpo> was observed </plain></SENT>
<SENT sid="12" pm="."><plain>Pooling across <z:hpo ids='HP_0000001'>all</z:hpo> the <z:mp ids='MP_0002038'>carcinomas</z:mp> provided strong evidence for association of fascin-1 with increased risk of mortality (HR = 1.44; CI 1.24 to 1.68; P &lt;0.001; n = 3,645), lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (RR = 1.36; CI 1.18 to 1.55; P &lt;0.001; n = 2,906) and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (1.76; 1.34 to 2.32; P &lt;0.001; n = 1,514) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Fascin-1 is associated consistently with increased risk of mortality in breast, colorectal and <z:hpo ids='HP_0011459'>esophageal carcinomas</z:hpo> and with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in colorectal and gastric <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="14" pm="."><plain>The results were stable to various sensitivity analyses and did not vary by predefined subgroups </plain></SENT>
<SENT sid="15" pm="."><plain>These data will assist rational decision making for focusing investigations of fascin-1 as a biomarker or therapeutic target onto the most relevant <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="16" pm="."><plain>Please see related commentary article here http://www.biomedcentral.com/1741-7015/11/53 </plain></SENT>
</text></document>